Matches in Nanopublications for { ?s ?p "[Overall, host SNPs affecting doxorubicin pharmacodynamics (CYBA rs4673) and alkylator detoxification (GSTA1 rs3957357) may predict outcome in R-CHOP21-treated DLBCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Overall, host SNPs affecting doxorubicin pharmacodynamics (CYBA rs4673) and alkylator detoxification (GSTA1 rs3957357) may predict outcome in R-CHOP21-treated DLBCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP293798.RAwoCeAF3nrDI07rztIihlJ6AvRSdjqzio2At6J2bwKBM130_assertion description "[Overall, host SNPs affecting doxorubicin pharmacodynamics (CYBA rs4673) and alkylator detoxification (GSTA1 rs3957357) may predict outcome in R-CHOP21-treated DLBCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293798.RAwoCeAF3nrDI07rztIihlJ6AvRSdjqzio2At6J2bwKBM130_provenance.
- assertion description "[Overall, host SNPs affecting doxorubicin pharmacodynamics (CYBA rs4673) and alkylator detoxification (GSTA1 rs3957357) may predict outcome in R-CHOP21-treated DLBCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_assertion description "[Overall, host SNPs affecting doxorubicin pharmacodynamics (CYBA rs4673) and alkylator detoxification (GSTA1 rs3957357) may predict outcome in R-CHOP21-treated DLBCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_provenance.
- NP338782.RAN73wmdElcLL-JcF88z2BHHhrTPy8__YiuFG_DfKX8zw130_assertion description "[Overall, host SNPs affecting doxorubicin pharmacodynamics (CYBA rs4673) and alkylator detoxification (GSTA1 rs3957357) may predict outcome in R-CHOP21-treated DLBCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338782.RAN73wmdElcLL-JcF88z2BHHhrTPy8__YiuFG_DfKX8zw130_provenance.
- NP739547.RAP_4o6000uhTAtjNeUA5w5pq2XAz3ltb3e0LmvrZeaFo130_assertion description "[Overall, host SNPs affecting doxorubicin pharmacodynamics (CYBA rs4673) and alkylator detoxification (GSTA1 rs3957357) may predict outcome in R-CHOP21-treated DLBCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739547.RAP_4o6000uhTAtjNeUA5w5pq2XAz3ltb3e0LmvrZeaFo130_provenance.
- NP739548.RAIf2VgbP7P9vx7s99ShjlJ8GbTwPq06IqtofGqFvYNBs130_assertion description "[Overall, host SNPs affecting doxorubicin pharmacodynamics (CYBA rs4673) and alkylator detoxification (GSTA1 rs3957357) may predict outcome in R-CHOP21-treated DLBCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739548.RAIf2VgbP7P9vx7s99ShjlJ8GbTwPq06IqtofGqFvYNBs130_provenance.